LLC «Vitrotest Bioreagent» is pleased to announce the expansion of its range of test kits for the diagnosis of EBV infections. Our catalog now includes the Vitrotest® EBV VCA-IgA kit for the qualitative and semiquantitative determination of IgA class antibodies to viral capsid antigen of Epstein-Barr Virus (VCA). This test kit is an important tool for assessing disease progression and treatment effectiveness. Moreover, elevated levels of IgA antibodies to the EBV capsid antigen serve as a clinically significant marker of the risk of developing nasopharyngeal carcinoma (NPC). Their timely detection contributes to early screening and prevention of NPC, particularly in endemic regions.
We invite you to learn more and place an order by contacting our sales department or browsing the updated catalog on our website.